BioSpace News Archive

Chemomab Awarded New U.S. Patent for CM-101, Its First-in-Class CCL24 Neutralizing Antibody

Chemomab Therapeutics, Ltd. today reported that the United States Patent and Trademark Office has issued a new patent for CM-101, Chemomab’s first-in-class monoclonal antibody that neutralizes CCL24, a novel disease target at the confluence of fibrosis and inflammation.

June 28, 2022
·
6 min read
Deals

Elandas and AccessSync Merger Delivers Seamless Solutions for Market Access Execution

Elandas, Inc. announced it has merged with long-standing partner AccessSync, LLC, a US-based strategic market access execution services provider.

June 28, 2022
·
2 min read
Drug Development

XyloCor Therapeutics Achieves Target Enrollment in Phase 2 EXACT Study of XC001 Novel Gene Therapy for Ischemic Heart Disease

XyloCor Therapeutics, a clinical-stage biopharmaceutical company developing novel gene therapies for cardiovascular disease, today announced it has achieved enrollment of target number of subjects in the Phase 2 portion of its ongoing Phase 1/2 clinical trial (EXACT) for refractory angina.

June 28, 2022
·
4 min read
Diagnostic ENT Devices to Add on More Revenues to ENT Devices Swelling from Over 1/4th of the Total Revenue, States Fact.MR

Extensive development of the new age technology has prompted ENT Device manufacturers to launch highly robust, durable and smart components, aimed at increasing life supports, providing renewed growth opportunities for ENT device industry, comments a Fact.MR analyst.

June 28, 2022
·
6 min read
Increasing Healthcare Expenditure to Drive Sales of Reprocessed Medical Devices at 14.9% CAGR through 2028: Fact.MR Survey

Fact.MR – A Market Research and Competitive Intelligence Provider: The reprocessed medical devices market stood at a valuation of US$ 2.05 Bn in 2020, and is projected to surge to US$ 5.9 Bn by the end of 2028.

June 28, 2022
·
7 min read
Obvious Preference for No Sting Barrier Sprays Due to Ease of Application and Uniformity, States Fact.MR

Fact.MR – A Market Research and Competitive Intelligence Provider: The global no sting barrier market is estimated to reach a valuation of US$ 707.5 million by 2032 expanding at an impressive CAGR of 7.2% during the forecast years.

June 28, 2022
·
6 min read
Drug Discovery Technologies Market Analysis of the Competitive Landscape, with a Forecast for 2031

Wilmington, Delaware, United States: Drug discovery is the process of discovering new medications for different purposes.

June 28, 2022
·
6 min read
Cardiac Rhythm Management Devices Market Segmentation and Analysis Report, 2030

Wilmington, Delaware, United States: Because of the increasing life expectancy and availability of high end medical technologies, the adoption of cardiac rhythm management devices has increased in the past few years.

June 28, 2022
·
7 min read
Anti-infective Drugs Market: Increase in Prevalence of Infectious Diseases across the Globe to Drive the Market

Wilmington, Delaware, United States: The global anti-infective drugs market is driven by increase in prevalence of infectious diseases across the globe.

June 28, 2022
·
6 min read
With 3/4th Revenue Share Interventional Studies to Continue Being the Prominent Revenue Stream in Omics Based Clinical Trials Market, Mentions Fact.MR

North America Is The Dominant Region In Omics Based Clinical Trials Markets With Absolute Dollar Opportunity Of US$ 13.4 Bn During The Forecast Period.

June 28, 2022
·
7 min read